World Drug Delivery and Formulation 2011

17th - 18th January 2011

Maritim ProArte Hotel Berlin, Germany

XSpray Microparticles AB Details

XSpray Microparticles AB

Company Profile:

XSpray Microparticles helps pharmaceutical companies to improve drug delivery by optimizing the performance of challenging drug substances, such as poorly soluble compounds, inhaled compounds and biomolecules. The company's proprietary RightSize^TM technology enables full control over particle design and production - simplifying drug formulation and extending delivery options. The technology is suitable for the development of new chemical entities as well as drug reformulation and lifecycle management. GMP facilities provide customers with high quality powders for use in clinical studies. The technology is also fully scalable to drug manufacturing volumes.

Key Products:

XSpray's RightSize^TM technology uses supercritical fluid as an antisolvent for controlled precipitation of an active pharmaceutical ingredient/drug substance. Customers benefit from better quality particles and a superior process compared to traditional methods. Key capabilities include:
Inhalable particles - offering accurate, reproducible production of small particles of specific sizes (1-5 µm size range) with a narrow size distribution. Both amorphous and crystalline particles can be produced with desired polymorph selection.
Nanosizing - generating nanoparticles from biomolecules as well as small organic molecules with consistent size below 200 nm.
Solid dispersions - providing improved supersaturation, good amorphous stability and minimum solvent residue.

Website:
www.xspray.com